logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Ovarian cancer: maintenance niraparib benefits partial chemotherapy responders

Post hoc analysis of phase 3 trial shows benefit regardless of BRCA status.